Medicine
Multaq 400 mg tablet
Multaq 400 mg tablet is a prescription medicine containing Dronedarone for oral use, marketed by Sanofi-Aventis, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature between 68°F to 77°F (20°C to 25°C): excursions…
Key facts
- Active ingredient (INN)
- Dronedarone
- Brand
- Multaq
- Strength
- 400 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets, 1260 tablets
- Marketing authorisation holder
- Sanofi-Aventis
- Manufacturers
- Sanofi-AventisCardinal Health
- Origin register
- US FDA, United States
- Storage
- Store at room temperature between 68°F to 77°F (20°C to 25°C): excursions permitted to 59°F–86°F (15°C–30°C),.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01BD07 Dronedarone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 July 2009
- Identifiers
- RxCUI 854856, 854859DailyMed set ID 7fa41601-7fb5-4155-8e50-2ae903f0d2d6, 3bd4006a-8bad-4909-ac6d-b6d84390155cNDC 0024-4142, 55154-8104Application NDA022425
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet, film coated in 1 bottle | 0024-4142-60 | Sanofi-Aventis | 1 July 2009 |
| 1260 tablet, film coated in 1 bottle | 55154-8104-2 | Cardinal Health | 1 July 2009 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Dronedarone is an antiarrhythmic indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (AF). It is available as tablets for oral use. MedsAcross supplies Dronedarone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DronedaroneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Multaq prescribing information (Sanofi-Aventis) · U.S. National Library of Medicine, DailyMed
- Multaq: European public assessment report (EPAR) · European Medicines Agency
Need Multaq 400 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.